Table 4.
Exposure-Disease Association in Humans | Evidence on in Vitro and in Vivo Mechanisms |
---|---|
Smoking and seropositive-RA | Post-translational modification—antigen citrullination and anti-cyclic citrullinated peptides (CCP) antibodies [80,82]; |
Nicotine and Th17 activation [86,87]; | |
Upregulation of heat shock gene expression [84] *; | |
Disease relevant autoantibodies (RF, anti-HSP70) [85] *. | |
Silica and RA/SLE/SSc/ANCA-vasculitis | Aggravation of lupus in animal models [88]; |
Adjuvant effect-apoptotic debris [88]; | |
Dysregulation of apoptosis [90] *; | |
Disease relevant autoantibodies (anti-dsDNA, anti-Ro/SSA, anti-La/SSB antibodies in silica associated SLE) [91] *; | |
Altered CD4+/CD4+ CD25+ T cell ratio [89] *. | |
Solvents and SSc | Accelerated autoimmunity in animal models [93] |
SSc disease relevant autoantibodies (anti-Scl-70) [92] | |
Increased IFN-γ, reduced IL-4 [93] * |
* Similar observations made in animal studies.